
### [NCIT:C5117](http://purl.obolibrary.org/obo/NCIT_C5117)
**Label:** Spiradenocarcinoma

**Subclasses:** [NCIT:C5180](http://purl.obolibrary.org/obo/NCIT_C5180) (Malignant Breast Eccrine Spiradenoma), [NCIT:C43344](http://purl.obolibrary.org/obo/NCIT_C43344) (Carcinoma ex Eccrine Spiradenoma), 

**Class expressions from DL-Learner:**

- [NCIT:C62208](http://purl.obolibrary.org/obo/NCIT_C62208) (Eccrine Differentiation) 75.00%
- [NCIT:C36329](http://purl.obolibrary.org/obo/NCIT_C36329) (TP53 Gene Inactivation) 75.00%
- [NCIT:C43573](http://purl.obolibrary.org/obo/NCIT_C43573) (Glandular Differentiation) and [NCIT:C62285](http://purl.obolibrary.org/obo/NCIT_C62285) (Adnexal Differentiation) 60.36%
- [NCIT:C43573](http://purl.obolibrary.org/obo/NCIT_C43573) (Glandular Differentiation) 53.87%
- Thing 50.92%
- [NCIT:C62285](http://purl.obolibrary.org/obo/NCIT_C62285) (Adnexal Differentiation) 43.90%
- [NCIT:C42585](http://purl.obolibrary.org/obo/NCIT_C42585) (Epithelial Differentiation) 38.87%
- [NCIT:C36334](http://purl.obolibrary.org/obo/NCIT_C36334) (Tumor-Suppressor Gene Inactivation) 35.91%
- [NCIT:C42095](http://purl.obolibrary.org/obo/NCIT_C42095) (Tissue Differentiation) 34.13%
- [NCIT:C36327](http://purl.obolibrary.org/obo/NCIT_C36327) (Gene Abnormality) 29.12%
- [NCIT:C36391](http://purl.obolibrary.org/obo/NCIT_C36391) (Molecular Genetic Variation) 28.64%
- [NCIT:C97926](http://purl.obolibrary.org/obo/NCIT_C97926) (Molecular Sequence Variation) 28.54%
- [NCIT:C35867](http://purl.obolibrary.org/obo/NCIT_C35867) (Morphologic Finding) 27.56%
- [NCIT:C83490](http://purl.obolibrary.org/obo/NCIT_C83490) (Microscopic Finding) 27.46%
- [NCIT:C3910](http://purl.obolibrary.org/obo/NCIT_C3910) (Molecular Abnormality) 27.21%


